Source:http://linkedlifedata.com/resource/pubmed/id/16569527
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2006-3-29
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1097-6744
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
151
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
757-61
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:16569527-Clinical Trials as Topic,
pubmed-meshheading:16569527-Defibrillators,
pubmed-meshheading:16569527-Device Approval,
pubmed-meshheading:16569527-Heart Failure,
pubmed-meshheading:16569527-Humans,
pubmed-meshheading:16569527-Outcome Assessment (Health Care),
pubmed-meshheading:16569527-Risk Assessment,
pubmed-meshheading:16569527-United States
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Cardiac resynchronization therapy: a regulatory perspective.
|
| pubmed:publicationType |
Editorial
|